MIMS Education

Managing Conditions Linked to Obesity: Updates from the MEMS Annual Congress 2022

Managing Conditions Linked to Obesity: Updates from the MEMS Annual Congress 2022

Internal MedicineEndocrinologyFamily MedicineGeneral Practice
A badge with ribbon in color black 1 Point | An analog clock in color black 1 hour | A black calendar with white triangle in center that has a black exclamation point in the middle 07 Oct 2023 

Overview

About this course

Obstructive sleep apnea (OSA) and non-alcoholic fatty liver disease (NAFLD) / metabolic dysfunction associated fatty liver disease (MAFLD) are two conditions commonly affecting individuals with metabolic disorders, particularly obesity. Prompt recognition of these diseases is important to reduce morbidity among obese patients. This e-learning module provides a brief overview on the diagnosis and management of obstructive sleep apnea and provides a primary care approach to fatty liver disease.

Learning outcomes

Upon completion of the educational activity, participants should be able to:
  • Understand OSA
  • Identify clinical characteristics of OSA
  • Review the diagnosis and initial management of OSA
  • Review metabolic dysfunction associated fatty liver disease (MAFLD)
  • Management of MAFLD

Topics covered

  • OSA
    • Overview
    • When to suspect OSA in patients
    • Initial things to do before referring to a specialist
    • Diagnosis
    • Treatment
  • Fatty Liver
    • Overview
    • NAFLD and MAFLD
    • Management of MAFLD
    • Fatty liver in patients with type 2 diabetes mellitus
Keywords: obesity, obstructive sleep apnea, fatty liver

In collaboration with:

MEMS logo final.png
Something went wrong.